cross-posted from: https://lemmy.ml/post/24390549

I missed this before, but apparently we’re now nearly a year into Merck and Moderna’s Phase-3 trials of a novel mRNA vaccine (mRNA-4157) in combination with Keytruda to slow or halt aggressive melanoma growth. (press release), and about 4 months into a similar Phase 3 trial of the same drug combo for small cell lung cancer (press release). Here’s hoping that 2025 is the year we cure (some kinds of) cancer!